Cryo-Cell plans spin-off of Celle Corp. and explores strategic alternatives including sale

CRYO CELL INTERNATIONAL INC

Board authorized spin-off of newly formed Celle Corp. via stock dividend to Cryo-Cell shareholders.
Spin-off expected in Q2 or Q3 2024; Celle Corp. holds Duke University license and other assets.
Company will explore equity/debt financings or possible sale/merger for post-spin-off Cryo-Cell.
No assurance that any transaction will occur; further details to be disclosed in SEC filings.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.